Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1955 1
1956 2
1957 4
1958 1
1959 2
1960 4
1961 3
1962 1
1963 3
1964 7
1965 4
1967 4
1968 1
1969 4
1970 2
1971 2
1973 2
1975 4
1976 1
1978 3
1979 3
1980 10
1981 12
1982 10
1983 15
1984 8
1985 10
1986 4
1987 5
1988 6
1989 5
1990 2
1991 3
1992 2
1993 5
1996 1
1997 1
1998 2
1999 2
2000 5
2001 1
2002 2
2004 1
2005 2
2006 3
2007 2
2008 1
2009 2
2010 1
2011 3
2012 2
2013 1
2015 1
2016 1
2017 1
2019 2
2020 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
Ambrose PJ. Ambrose PJ. Clin Pharmacokinet. 1984 May-Jun;9(3):222-38. doi: 10.2165/00003088-198409030-00004. Clin Pharmacokinet. 1984. PMID: 6375931 Review.
Incomplete bioavailability is the result of renal excretion of unchanged chloramphenicol succinate prior to it being hydrolysed to active chloramphenicol. ...Inaccurate determinations of the pharmacokinetic parameters may result by incorrectly assuming rapid and com …
Incomplete bioavailability is the result of renal excretion of unchanged chloramphenicol succinate prior to it being hydrolyse …
Absorption of chloramphenicol sodium succinate after intramuscular administration in children.
Shann F, Linnemann V, Mackenzie A, Barker J, Gratten M, Crinis N. Shann F, et al. N Engl J Med. 1985 Aug 15;313(7):410-4. doi: 10.1056/NEJM198508153130703. N Engl J Med. 1985. PMID: 4022068
Fifty-seven children were studied on 62 occasions while they were receiving chloramphenicol sodium succinate (25 mg of chloramphenicol per kilogram of body weight) intramuscularly every six hours. ...Thirteen children were studied on 17 occasions while they w …
Fifty-seven children were studied on 62 occasions while they were receiving chloramphenicol sodium succinate (25 mg of …
Chloramphenicol sodium succinate kinetics in critically ill patients.
Slaughter RL, Pieper JA, Cerra B, Brodsky B, Koup JR. Slaughter RL, et al. Clin Pharmacol Ther. 1980 Jul;28(1):69-77. doi: 10.1038/clpt.1980.133. Clin Pharmacol Ther. 1980. PMID: 7389257
Chloramphenicol sodium succinate (SCAP) kinetics were studied in 10 critically ill patients. ...
Chloramphenicol sodium succinate (SCAP) kinetics were studied in 10 critically ill patients. ...
Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.
Burke JT, Wargin WA, Sherertz RJ, Sanders KL, Blum MR, Sarubbi FA. Burke JT, et al. J Pharmacokinet Biopharm. 1982 Dec;10(6):601-14. doi: 10.1007/BF01062543. J Pharmacokinet Biopharm. 1982. PMID: 7182457
The pharmacokinetics of chloramphenicol (CAP) and total chloramphenicol succinate (CAPS) were studied in eight hospitalized adult patients with normal renal and hepatic function receiving intravenous chloramphenicol sodium succinate therapy. The …
The pharmacokinetics of chloramphenicol (CAP) and total chloramphenicol succinate (CAPS) were studied in eight hospitalized ad …
Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus).
Black LA, McLachlan AJ, Griffith JE, Higgins DP, Gillett A, Krockenberger MB, Govendir M. Black LA, et al. J Vet Pharmacol Ther. 2013 Oct;36(5):478-85. doi: 10.1111/jvp.12024. Epub 2012 Nov 17. J Vet Pharmacol Ther. 2013. PMID: 23157306
Clinically normal koalas (n = 19) received a single dose of intravenous (i.v.) chloramphenicol sodium succinate (SS) (25 mg/kg; n = 6), subcutaneous (s.c.) chloramphenicol SS (60 mg/kg; n = 7) or s.c. chloramphenicol base (60 mg/kg; n = 6). ...
Clinically normal koalas (n = 19) received a single dose of intravenous (i.v.) chloramphenicol sodium succinate (SS) (2 …
Pharmacokinetic, residue and irritation aspects of chloramphenicol sodium succinate and a chloramphenicol base formulation following intramuscular administration to ruminants.
Nouws JF, Vree TB, Holtkamp J, Baakman M, Driessens F, Guelen PJ. Nouws JF, et al. Vet Q. 1986 Jul;8(3):224-32. doi: 10.1080/01652176.1986.9694046. Vet Q. 1986. PMID: 3750804
The disposition of chloramphenicol (CAP) and of its glucuronide metabolite in plasma and milk was studied following a single intramuscular injection of a chloramphenicol base formulation (Amicol Forte; product A) and of chloramphenicol sodium succinate (produ …
The disposition of chloramphenicol (CAP) and of its glucuronide metabolite in plasma and milk was studied following a single intramuscular i …
Chloramphenicol sodium succinate in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration.
Brown MP, Kelly RH, Gronwall RR, Stover SM. Brown MP, et al. Am J Vet Res. 1984 Mar;45(3):578-80. Am J Vet Res. 1984. PMID: 6711989
Six healthy adult mares were given a single IV dose (25 mg/kg of body weight) of chloramphenicol sodium succinate. Chloramphenicol concentrations in serum, synovial fluid, peritoneal fluid, and urine were measured serially over a 48-hour period. ...
Six healthy adult mares were given a single IV dose (25 mg/kg of body weight) of chloramphenicol sodium succinate. Chlo …
Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters.
Pickering LK, Hoecker JL, Kramer WG, Kohl S, Cleary TG. Pickering LK, et al. J Pediatr. 1980 Apr;96(4):757-61. doi: 10.1016/s0022-3476(80)80762-1. J Pediatr. 1980. PMID: 6987361
The clinical pharmacology of chloramphenicol was evaluated in 14 children with serious bacterial infections. The children received chloramphenicol sodium succinate intravenously for five to six days at which time orally administered chloramphenicol palmitate …
The clinical pharmacology of chloramphenicol was evaluated in 14 children with serious bacterial infections. The children received chlora …
Chloramphenicol: new perspectives on an old drug.
Powell DA, Nahata MC. Powell DA, et al. Drug Intell Clin Pharm. 1982 Apr;16(4):295-300. doi: 10.1177/106002808201600404. Drug Intell Clin Pharm. 1982. PMID: 7040026 Review.
Because of this renewed popularity and the recent availability of accurate analytical techniques for measurement of chloramphenicol, there have been many recent articles examining the pharmacokinetics of chloramphenicol and its two major prodrug esters, chloramphenicol …
Because of this renewed popularity and the recent availability of accurate analytical techniques for measurement of chloramphenicol, there h …
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
Nahata MC, Powell DA. Nahata MC, et al. Clin Pharmacol Ther. 1981 Sep;30(3):368-72. doi: 10.1038/clpt.1981.174. Clin Pharmacol Ther. 1981. PMID: 7273601
Bioavailability of chloramphenicol and kinetics of chloramphenicol succinate and chloramphenicol were studied in 12 patients. Chloramphenicol succinate, 25 mg/kg, was injected intravenously every 6 hr over 0.5 to 1 hr. ...
Bioavailability of chloramphenicol and kinetics of chloramphenicol succinate and chloramphenicol were studied in 12 patients. …
193 results